These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 34794376)

  • 41. Gastroesophageal reflux disease after peroral endoscopic myotomy is unpredictable, but responsive to proton pump inhibitor therapy: a large, single-center study.
    Nabi Z; Ramchandani M; Kotla R; Tandan M; Goud R; Darisetty S; Rao GV; Reddy DN
    Endoscopy; 2020 Aug; 52(8):643-651. PubMed ID: 32208499
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Randomized Trial of Medical versus Surgical Treatment for Refractory Heartburn.
    Spechler SJ; Hunter JG; Jones KM; Lee R; Smith BR; Mashimo H; Sanchez VM; Dunbar KB; Pham TH; Murthy UK; Kim T; Jackson CS; Wallen JM; von Rosenvinge EC; Pearl JP; Laine L; Kim AW; Kaz AM; Tatum RP; Gellad ZF; Lagoo-Deenadayalan S; Rubenstein JH; Ghaferi AA; Lo WK; Fernando RS; Chan BS; Paski SC; Provenzale D; Castell DO; Lieberman D; Souza RF; Chey WD; Warren SR; Davis-Karim A; Melton SD; Genta RM; Serpi T; Biswas K; Huang GD
    N Engl J Med; 2019 Oct; 381(16):1513-1523. PubMed ID: 31618539
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Algorithmic approach to patients presenting with heartburn and epigastric pain refractory to empiric proton pump inhibitor therapy.
    Roorda AK; Marcus SN; Triadafilopoulos G
    Dig Dis Sci; 2011 Oct; 56(10):2871-8. PubMed ID: 21512760
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Feasibility and outcomes of anti-reflux mucosectomy for proton pump inhibitor dependent gastroesophageal reflux disease: First Indian study (with video).
    Patil G; Dalal A; Maydeo A
    Dig Endosc; 2020 Jul; 32(5):745-752. PubMed ID: 31834663
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Endoscopic full-thickness plication for the treatment of gastroesophageal reflux disease using multiple Plicator implants: 12-month multicenter study results.
    von Renteln D; Schiefke I; Fuchs KH; Raczynski S; Philipper M; Breithaupt W; Caca K; Neuhaus H
    Surg Endosc; 2009 Aug; 23(8):1866-75. PubMed ID: 19440792
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Adding Acotiamide to Gastric Acid Inhibitors Is Effective for Treating Refractory Symptoms in Patients with Non-erosive Reflux Disease.
    Yamashita H; Okada A; Naora K; Hongoh M; Kinoshita Y
    Dig Dis Sci; 2019 Mar; 64(3):823-831. PubMed ID: 30465175
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Proton pump inhibitors in the management of gastroesophageal reflux disease.
    Hrelja N; Zerem E
    Med Arh; 2011; 65(1):52-5. PubMed ID: 21534455
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Gastroesophageal reflux disease in primary care: using changes in proton pump inhibitor therapy as an indicator of partial response.
    Ruigómez A; Johansson S; Wernersson B; Fernández Cantero O; García Rodríguez LA
    Scand J Gastroenterol; 2012 Jul; 47(7):751-61. PubMed ID: 22519917
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Management of gastroesophageal reflux disease: medications, surgery, or endoscopic therapy? (Current status and trends).
    Zhi XT; Kavic SM; Park AE
    J Long Term Eff Med Implants; 2005; 15(4):375-88. PubMed ID: 16022648
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Diagnostic work-up of GERD.
    Vela MF
    Gastrointest Endosc Clin N Am; 2014 Oct; 24(4):655-66. PubMed ID: 25216910
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Is the proton pump inhibitor test helpful in patients with laryngeal symptoms?
    Kim JH; Sung IK; Hong SN; Lee SY; Park HS; Shim CS
    Dig Dis Sci; 2013 Jun; 58(6):1663-7. PubMed ID: 23443492
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Refractory gastroesophageal reflux disease.
    Moraes-Filho JP
    Arq Gastroenterol; 2012 Dec; 49(4):296-301. PubMed ID: 23329226
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Investigation of pretreatment prediction of proton pump inhibitor (PPI)-resistant patients with gastroesophageal reflux disease and the dose escalation challenge of PPIs-TORNADO study: a multicenter prospective study by the Acid-Related Symptom Research Group in Japan.
    Furuta T; Shimatani T; Sugimoto M; Ishihara S; Fujiwara Y; Kusano M; Koike T; Hongo M; Chiba T; Kinoshita Y;
    J Gastroenterol; 2011 Nov; 46(11):1273-83. PubMed ID: 21861141
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of Helicobacter pylori eradication on reflux esophagitis and GERD symptoms after endoscopic resection of gastric neoplasm: a single-center prospective study.
    Na HK; Lee JH; Park SJ; Park HJ; Kim SO; Ahn JY; Kim DH; Jung KW; Choi KD; Song HJ; Lee GH; Jung HY
    BMC Gastroenterol; 2020 Apr; 20(1):123. PubMed ID: 32316932
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Association of residual gastric acid secretion with persistent symptoms in gastroesophageal reflux disease patients receiving standard-dose proton pump inhibitor therapy.
    Kikuchi H; Fukuda S; Koike T; Shimodaira Y; Watanabe K; Saito M; Nakagawa K; Hatta W; Masamune A; Iijima K
    Esophagus; 2021 Apr; 18(2):380-387. PubMed ID: 32737802
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Endotherapy for and tailored approaches to treating GERD, and refractory GERD.
    Locke GR; Horwhat J; Mashimo H; Savarino E; Zentilin P; Savarino V; Zerbib F; Armbruster SP; Wong RK; Moawad F
    Ann N Y Acad Sci; 2013 Oct; 1300():166-186. PubMed ID: 24117641
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Anti-reflux mucosal ablation (ARMA) as a new treatment for gastroesophageal reflux refractory to proton pump inhibitors: a pilot study.
    Inoue H; Tanabe M; de Santiago ER; Abad MRA; Shimamura Y; Fujiyoshi Y; Ueno A; Sumi K; Tomida H; Iwaya Y; Ikeda H; Onimaru M
    Endosc Int Open; 2020 Feb; 8(2):E133-E138. PubMed ID: 32010745
    [No Abstract]   [Full Text] [Related]  

  • 58. [Gastroesophageal reflux].
    Schwizer W; Fried M
    Ther Umsch; 1997 Nov; 54(11):611-6. PubMed ID: 9454361
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Potassium-competitive acid blockers and gastroesophageal reflux disease.
    Leowattana W; Leowattana T
    World J Gastroenterol; 2022 Jul; 28(28):3608-3619. PubMed ID: 36161043
    [TBL] [Abstract][Full Text] [Related]  

  • 60. How many cases of laryngopharyngeal reflux suspected by laryngoscopy are gastroesophageal reflux disease-related?
    de Bortoli N; Nacci A; Savarino E; Martinucci I; Bellini M; Fattori B; Ceccarelli L; Costa F; Mumolo MG; Ricchiuti A; Savarino V; Berrettini S; Marchi S
    World J Gastroenterol; 2012 Aug; 18(32):4363-70. PubMed ID: 22969200
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.